GESTATIONAL DIABETES MELLITUS - PowerPoint Presentation

Slide1

GESTATIONAL DIABETES MELLITUSDr Abha GuptaProfessor of Medicine, LLRM Medical College, Meerut 

Slide2

Definition

Slide3

Carbohydrate intolerance of any degree with onset or first recognition during pregnancy.ADA (2014 guidelines) defined GDM as “diabetes diagnosed during pregnancy that is not clearly overt diabetes”.

Slide4

Epidemiology

Slide5

The overall worldwide prevalence :1% - 20%. International Diabetes federation (2013) : worldwide 16% live births complicated by hyperglycemia during pregnancy.In a study from Haryana the prevalence was GDM was found to be 7.1% while in another study from South India it was 16.55%

Slide6

WHO Criteria 1999

Slide7

GDM to be diagnosed if any of the following criteria is met: FPG ≥ 126 mg/dl (7 mmol/L)2hr post 75 gm OGTT ≥ 140 mg/dl ( 7.8

mmol/L)

Slide8

NEED TO CHANGE DIAGNOSTIC CRITERIA

Slide9

Was not evidence based, over 10 years old hence needed to be updated in light of new dataDoes not differentiate between overt diabetes and glucose intolerance in pregnancy.The diagnostic level of FPG ≥ 126mg/dl( 7 mmol/lt) – universally considered to be too high.

Slide10

Diabetes during pregnancy, symptomatic or not , is associated with adverse pregnancy outcomes- what level of hyperglycemia should be treated is not clear. Difference in the management approach in overt diabetes and impaired glucose tolerance during pregnancy.

Slide11

WHO -2013 criteria Diabetes in pregnancy : Any of the following

Parameters

Level

fasting plasma glucose

≥ 7.0

mmol

/l (126 mg/ dl)

2-hour plasma glucose following a 75g oral glucose load

≥ 11.1

mmol

/l (200 mg/dl)

random plasma glucose in the presence of diabetes symptoms

≥ 11.1

mmol

/l (200 mg/ dl)

Gdm

:

Any of the following

Parameters

Level

fasting plasma glucose

≥5.1-6.9

mmol

/l (92 -125 mg/dl)

1-hour plasma glucose following a 75g oral glucose load

≥ 10.0

mmol/l (180 mg/dl) 2-hour plasma glucose following a 75g oral glucose load≥ 8.5-11.0 mmol/l (153 -199 mg/dl)

Diagnostic criteria for GDM is based on adverse pregnancy outcomes as derived from HAPO, 2008 (Hyperglycemia and adverse pregnancy outcomes)study and the recommendations of IADPSG (International assoc. Of Diabetes & pregnancy study group) consensus panel.

Slide12

ADA’s “One-Step” Strategy for GDM75-g OGTT, after overnight fast (≥8 h), with PG measurement fasting and at 1 h and 2 h, at 24-28 wks in women not previously diagnosed with overt diabetes  GDM diagnosis made if PG values meet or exceed: Fasting: 92 mg/dl (5.1 mmol/L)

1 h: 180 mg/dl (10.0 mmol/L)2 h: 153 mg/dl (8.5 mmol/L) 

Slide13

ADA’s “Two-Step” Strategy for GDM 50-g GLT (nonfasting) with PG measurement at 1 h (Step 1), at 24-28 wks in women not previously diagnosed with overt diabetesIf PG at 1 h after load is ≥140 mg/dl 

(7.8 mmol/L), proceed to 100-g OGTT (Step 2), performed while patient is fastingGDM diagnosis made when two or more PG levels meet or exceed:

Fasting: 95 mg/dl or 105 mg/dl (5.3/5.8)

1 hr: 180 mg/dl or 190 mg/dl (10.0/10.6)

2 hr: 155 mg/dl or 165 mg/dl (8.6/9.2)

3 hr: 140 mg/dl or 145 mg/dl (7.8/8.0)

Slide14

Pathophysiology of GDM

Slide15

Progressive insulin resistance No adequate insulin GDM Placental hormonesMaternal adiposity 

diabetogenic adipokines

Defect in β-cell insulin secretion

- Defective first phase insulin response

- Lower insulin response to given glycemic stimulus

Slide16

Whom & when to screen??

Slide17

High risk patientsHigher pre-pregnant BMI > 27 kg/m2Increased gestational weight gainEthnicity

 South Asian, Middle East, Black CaribbeanMaternal age over 25 years

Previous GDM

Previous

macrosomic

baby

weighing 4.5 kg or above,

Multiparity

Twin pregnancy

Family history of diabetes(first-degree relative with diabetes)

Slide18

When to screen Women with previous GDMAs soon as possible after bookingRepeat at 24-28 weeks if first test normal

All other high risk women - 24-28 weeks

Screening



75 gm 2 hr OGTT

- NICE 2015

Slide19

Maternal & Fetal complications

Slide20

Maternal complications MiscarriagePre-eclampsia/ hypertensive disorders of pregnancyIncreased obstetric interventionsLong term maternal increased risk of T2DM (50% in next 20 years),

CVD,Metabolic

syn

Slide21

Fetal complications Unexplained stillbirthMacrosomia/LGA babyShoulder dystociaNeonatal hypoglycemia/hypocalcemia/ hyperbilirubinemia

Delayed lung maturityLong term-Childhood obesity(2 fold), T2DM (6 fold)and metabolic syndrome(4 fold)

Slide22

Why to treat??GDM has been demonstrated to be an independent risk factor for various adverse pregnancy outcomes. HAPO study(Hyperglycemia and adverse pregnancy outcomes-2008)- international multicentric

cohort of 25,505 pregnant womenGDM treatment consistently demonstrates significant decreases in adverse outcomes such as macrosomia, LGA , shoulder

dystocia

, preeclampsia and

and

obstetric interventions.

- .ACHOIS Study -2005

-Systematic review by Flavinga et al- effectiveness of GDM treatment. Diabetic research and clinical practice , 2012

Slide23

Management of GDM

Slide24

Glycemic Targets in Pregnancy- ADA (2015)GDM targets  

Preprandial

: ≤95* mg/

dL

(5.3

mmol

/L) 

and either

 

1-hr

postmeal

: ≤140 mg/

dL

(7.8

mmol

/L)

2-hr

postmeal

: ≤120 mg/

dL

(6.7 mmol/)

*

Diabetes in Pregnancy Study Group India

 90mg%

Targets for preexisting type 1 or 2 DM Premeal, bedtime, overnight glucose: 60-99 mg/dL (3.3-5.4 mmol/L)Peak postprandial glucose: 100-129 mg/

dL (5.4-7.1 mmol/L)A1C: <6.0%

For GDM pts on pharmacotherapy maintain plasma glucose levels : >4mmol/lt (72 mg/dl) – NICE 2015

Slide25

Management components Medical Nutrition TherapyPhysical exercise  30 min walk (NICE 2015)PharmacotherapySMBGCounseling regarding hypoglycemic symptoms

Slide26

Medical Nutrition Therapy

Slide27

Carbohydrate controlled meal plan that promotes adequate nutrition and appropriate weight gain, normoglycemia and absence of ketosis.Food plan must be flexible and should incorporate modifiable components

Slide28

CaloriesIBW – 30 kcal/kg/dOverweight (1.2 – 1.5 X IBW) – 24kcal/kg/dObese > 1.5 X IBW – 12-15 kcal/kg/dUnderweight < 0.8 X IBW – 40 kcal/kg/d

Components Carbohydrate 40%

Protein 20%

Fat 40 % (saturated < 7%)

Slide29

Since there is defect in first phase of insulin secretion the challenge of quantity of food at one time should be less.3 major meals and 3 snacks per day- Total calories to be divided into 9 portions- 2 portions = major meal1 portions = snack

Slide30

Decreased carbohydrate load in the breakfastMorning cortisol surge (Dawn phenomenon) release of blood glucose from stored sources and hepatic

gluconeogenesis high blood glucose levels.

Split the breakfast portion into two equal halves  prevents undue peak in blood glucose levels.

Bedtime snack prevents accelerated starvation and ketosis overnight.

Slide31

Pharmacotherapy

Slide32

Pharmacological managementADA, ACOG, NICE, Diabetes in Pregnancy Study Group in India recommends insulin for maternal hyperglycemia not meeting the target levels even with diet and exercise after about 2 weeks. Most insulins are category B; glargine and glulisine

are category C.

Slide33

Status of OHA

Slide34

Metformin is commonly used because of strong evidence of its effectiveness in pregnancy and lactation with minimal risk of teratogenisity (pregnancy cat B, USFDA approved-1995, yet not by UK marketing authorization)

Slide35

Oral hypoglycemics like glibenclamide can be considered (during second and third trimester) in patients in whom blood glucose targets are not met with metformin but who decline insulin therapy or who cannot tolerate metformin.

Acarbose-found safe in pergnancy.(

Bertini

et

al,perinatal

outcomes &use of OHA.J

Perinat

med.2005

)

Slide36

Antenatal management -Oral hypoglycemics (contd.)Noninsulin medications lack sufficient long-term safety data Because of limited safety data global recommendations still have kept insulin as the drug of choice.

Slide37

Labor and delivery

Slide38

Target glucose of 80 to 110 mg/dLMaternal glucose > 110 mg/dL insulin drip

If the woman does not require insulin during the prenatal period, labor and delivery can likely proceed without special attention to maternal glycemia.

If insulin is required, and labor and delivery are to be scheduled, it is preferable to schedule for the morning hours. In this case, the usual insulin dose can be administered the evening before the scheduled delivery, and the morning dose can be held.

Slide39

If the mother took insulin and spontaneous labor ensues, a dextrose infusion with the rate adjusted to a target glucose of 80 to 110 mg/dL may be required to prevent maternal hypoglycemia.The infant is at greatest risk of hypoglycemia in the first hours after birth therefore mother should feed their babies as soon as possible after birth and then at frequent intervals

Slide40

Post-partum – ABCDEFG of post- partum careA- assessment of hyperglycemic statusB- breastfeedingC- contraception

(avoid progesterone-only therapy)D

- diet

E

- exercise

F

- family oriented motivation & education

G

- goals

Slide41

All patients with GDM should continue lifestyle management including diet , regular physical exercise and maintenance of ideal body weight

Slide42

Post-partum screeningWomen with GDM to be reclassified at 6 weeks with 75gm OGTT (ADA)If BS profile – WNL  reassess every 3 yearsIf results  prediabetic

rangeassess

annually

If results  diabetic range manage as a case of diabetes

Slide43

Goals of postpartum careMaintaining euglycemic statusMonitoring cardiometabolic parameters -BPLipid profile

Weight control

Slide44

Key notes…Since the HAPO and other studies have shown that the association of risk of adverse pregnancy outcomes is continuous with increasing glucose level, WHO new (2013) diagnostic criteria for GDM is based on prognostic accuracy meaning risk of adverse pregnancy outcomes rather than on diagnostic accuracy.Maternal metabolic characteristics are crucial determinants of insulin resistance during pregnancy and in offsprings

.

Slide45

Treatment of GDM is effective in reducing many adverse outcomes , the risk reduction for these outcomes is in general large, the no. to treat is low and the quality of evidence is adequate, which justifies treatment of GDM.Treatment of choice is diet , physical exercise with/without insulin.

Slide46

Interventions esp. healthy diet, exercise & weight reduction before ,during and after pregnancy might be a key to prevent the vicious cycle that contributes to the epidemic of obesity, insulin resistance and Type 2 DM .

Slide47